Fancl Corporation (TYO: 4921)
Japan
· Delayed Price · Currency is JPY | Market Cap | 338.35B |
| Revenue (ttm) | 109.77B |
| Net Income (ttm) | 8.32B |
| Shares Out | 120.97M |
| EPS (ttm) | 68.51 |
| PE Ratio | 40.83 |
| Forward PE | 32.11 |
| Dividend | 34.00 (1.22%) |
| Ex-Dividend Date | Mar 28, 2024 |
| Volume | 280,000 |
| Open | 2,797.00 |
| Previous Close | 2,797.00 |
| Day's Range | 2,792.00 - 2,800.00 |
| 52-Week Range | 1,787.00 - 2,958.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 1, 2024 |
About Fancl
Fancl Corporation engages in the research and development, manufacture, and sale of cosmetics and health food products in Japan, China, North America, Europe, the Middle East, Asia, and Oceania. The company provides cosmetics, quasi-drugs, nutritional supplements, and other products. It also offers germinated brown rice and kale juice products; develops and distributes undergarments, garments, and fashion goods; distributes cosmetics, nutritional supplements, miscellaneous goods, etc.; and produces and distributes OEM cosmetics and quasi-drugs.... [Read more]
Financial Performance
In 2023, Fancl's revenue was 110.88 billion, an increase of 7.03% compared to the previous year's 103.60 billion. Earnings were 8.83 billion, an increase of 77.73%.
Financial StatementsNews
Japan’s Kirin Again Extends Tender Offer Deadline for Fancl
Kirin Holdings Co. again extended its tender offer deadline for Fancl Corp., as the Japanese brewer works to secure a deal for the Japanese skincare and health supplement maker.